{"id":"NCT00296322","sponsor":"Asan Medical Center","briefTitle":"Trial of Adjuvant Chemotherapy for Gastric Cancer","officialTitle":"A Phase III Randomized Controlled Trial of Adjuvant Chemotherapy for Gastric Adenocarcinoma: Mitomycin and Doxifluridine Versus Intraperitoneal Chemotherapy and Mitomycin, Doxifluridine, and Cisplatin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-10","primaryCompletion":"2007-12","completion":"2010-03","firstPosted":"2006-02-27","resultsPosted":"2012-09-06","lastUpdate":"2020-01-18"},"enrollment":528,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Stomach Cancer"],"interventions":[{"type":"DRUG","name":"cisplatin, mitomycin-C, doxifluridine","otherNames":[]}],"arms":[{"label":"Mitomycin-C, Doxifluridine","type":"ACTIVE_COMPARATOR"},{"label":"Mitomycin-C, Doxifluridine, Cisplatin","type":"ACTIVE_COMPARATOR"}],"summary":"This study is designed to evaluate the efficacy of the intraperitoneal chemotherapy with early mitomycin administration and adding cisplatin to prolonged treatment with doxifluridine compared to mitomycin plus doxifluridine in resected advanced gastric cancer.","primaryOutcome":{"measure":"Relapse-free Survival","timeFrame":"3 years","effectByArm":[{"arm":"Mitomycin and Short-term Fluoropyrimidine","deltaMin":50,"sd":null},{"arm":"iceMFP","deltaMin":60.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":9},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":258},"commonTop":["Anemia","Fatigue","Anorexia","Nausea","Neutropenia"]}}